The Swiss pharmaceutical sector supplies medicines all over the world, but not all countries have the same price tag. Here because.
This content was published on
April 30, 2024 – 08:26
Céline Stegmüller
Céline joined swissinfo.ch in 2018 as a video journalist for the “Nouvo in English” project immediately after graduating from the Academy of Journalism and Media (AJM) at the University of Neuchâtel. Originally from Ticino, she has been writing, filming, and interviewing people all over Switzerland since she received her first press card at the age of 11 during a school trip.
Jessica Davis Plus
Jessica writes about the good, the bad and the ugly when it comes to multinationals and their impact in Switzerland and abroad. She is always looking for the Swiss connection to her native San Francisco and she willingly discusses how her hometown has produced some of the greatest innovations, but she can’t seem to solve the housing crisis.
The procedures for determining the value of a new drug are long, partly confidential and many factors play an important role. Governments, health insurers and other financiers have a say in finalizing the list price announced by the manufacturer.
